Verapamil for severe hyperkinetic movement disorders.
The use of verapamil in three cases of severe hyperkinetic movement disorders resulted in dramatic improvement in patients who had been refractory to many other treatments over a prolonged period. A videotape illustration of one of the patients is provided. The mechanism of action and evidence of efficacy of calcium-channel blockers for abnormal movements are discussed.
Ovsiew
F
F
University of Chicago, Illinois, USA.
Meador
K J
KJ
Sethi
K
K
D000328:Adult; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D008297:Male; D009460:Neurologic Examination / Q000187:drug effects; D014700:Verapamil / Q000627:therapeutic use*
D002121:Calcium Channel Blockers; D014700:Verapamil